Enrichment analysis of genes dysregulated following Ascorbic acid treatment
Canned Analysis
FAIR Metrics
0 evaluations
General Information
AccessionDCA00013973
TitleEnrichment analysis of genes dysregulated following Ascorbic acid treatment
DescriptionAn enrichment analysis was performed on the top most dyresgulated genes determined by applying the principal angle method to compare gene expression between Ascorbic acid treated cells and untreated control cells in the Mc3T3-E1 osteoblast (OB) cell line (50ug of ascorbic acid for 5 days) cell type.
Analysis URLhttp://amp.pharm.mssm.edu/PAEA?id=3088469
Upload DateSeptember 20, 2017
Uploadermaayanlab
Metadata
Analysis Curatorcadimo
CREEDS IDdrug:3132
Cell TypeMc3T3-E1 osteoblast (OB) cell line (50ug of ascorbic acid for 5 days)
Drug NameAscorbic acid
Organismmouse
PubChem CID54670067
SMILES IDC(C(C1C(=C(C(=O)O1)O)O)O)O
Characteristic Direction parameters
Control SamplesGSM925429, GSM925430, GSM925431
Perturbed SamplesGSM925432, GSM925433, GSM925434
Tools used in the analysis
Dataset Accession
PAEA
Published November 2015
Enrichment analysis tool implementing the principal angle method
3879
Characteristic Direction
Published March 2014
A geometrical multivariate approach to identify differentially expressed genes
26829
Datasets used in the analysis
Keyword
Tool Name
GSE37676
Gene Expression Omnibus
Ascorbic acid effect on Mc3T3 osteoblasts
7
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.